Catalent | CTLT - Ebitda



Ebitda Alterar Data
Agilent USD 540M 74M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Centene USD -903M 1.02B 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Elevance Health USD 2.19B 1.01B 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Humana USD -290M 1.11B 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.68B 418M 2025-09
Merck EUR 1.44B 263M 2025-12
Merck USD 8.39B 1.97B 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Quest Diagnostics USD 557M 20M 2026-03
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
UnitedHealth USD 9.99B 8.5B 2026-03
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 218.5M 5.4M 2025-12